Genmab A GMAB
NASDAQ GMAB
$39.46 +0.39 (+0.99%)
As of: Oct 21, 2026 · 1:57 PM EDT

Genmab A (GMAB) Other Working Capital Changes (2023 - 2026)

Updated

Genmab A's Other Working Capital Changes came in at -$3 million for the quarter ended Jun 30, 2026.

Analysis

Genmab A (GMAB) Other Working Capital Changes (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,134.24 Bn 1,102.83 Bn 19.71 Bn
2 Johnson & Johnson 616.11 Bn 534.64 Bn 17.26 Bn
3 AbbVie 501.21 Bn 474.32 Bn 12.70 Bn
4 Merck 367.51 Bn 321.89 Bn 12.21 Bn
5 Novartis Ag 297.95 Bn 261.94 Bn 11.24 Bn
6 Astrazeneca 261.35 Bn 235.03 Bn 12.86 Bn
7 Amgen 235.88 Bn 191.28 Bn 7.24 Bn
8 Gilead Sciences 190.74 Bn 164.94 Bn 6.22 Bn
9 Pfizer 169.40 Bn 116.05 Bn 10.94 Bn
10 Genmab A 2.55 Bn -2.82 Bn 1.07 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -18.00 Mn
Mar 31, 2026 -261.00 Mn
Mar 31, 2025 -46.00 Mn
Mar 31, 2024 29.00 Mn
Dec 31, 2023 -535.00 Mn
API Access

Genmab A Other Working Capital Changes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-working-capital-changes&ticker=GMAB&period=max&api_key=YOUR_API_KEY